Paper1887859
Transgenic oncogene mice. Tumor phenotype predicts genotype.
Cardiff RD and 3 others. Am J Pathol, 1991. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Transgenic oncogene mice. Tumor phenotype predicts genotype. Papers, record 1887859. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1887859
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mammary Neoplasms, Experimental | Major topic |
| Mice, Transgenic | Major topic |
| Oncogenes | Major topic |
| Animals | |
| Genes, myc | |
| Genes, ras | |
| Genotype | |
| Mice | |
| Phenotype |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6488314 | Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. | Cell | 1984 | https://conductscience.org/library/papers/6488314 | PubMed |
| 2 | 2470152 | Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. | Science | 1989 | https://conductscience.org/library/papers/2470152 | PubMed |
| 3 | 2566812 | HER2/neu amplification and comedo type breast carcinoma. | Lancet | 1989 | https://conductscience.org/library/papers/2566812 | PubMed |
| 4 | 3058236 | Expression of p21 ras gene products in breast cancer relates to histological types and to receptor and nodal status. | Breast Cancer Res Treat | 1988 | https://conductscience.org/library/papers/3058236 | PubMed |
| 5 | 2903446 | Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. | N Engl J Med | 1988 | https://conductscience.org/library/papers/2903446 | PubMed |
| 6 | 3276529 | Cellular and molecular aspects of neoplastic progression in the mammary gland. | Eur J Cancer Clin Oncol | 1988 | https://conductscience.org/library/papers/3276529 | PubMed |
| 7 | 3032456 | Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. | Cell | 1987 | https://conductscience.org/library/papers/3032456 | PubMed |
| 8 | 2511965 | Breast cancer and a proto-oncogene. | BMJ | 1989 | https://conductscience.org/library/papers/2511965 | PubMed |
| 9 | 2677520 | Molecular diagnosis of human cancer. | Lab Invest | 1989 | https://conductscience.org/library/papers/2677520 | PubMed |
| 10 | 2672826 | Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. | Am J Pathol | 1989 | https://conductscience.org/library/papers/2672826 | PubMed |
| 11 | 2898299 | Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. | Cell | 1988 | https://conductscience.org/library/papers/2898299 | PubMed |
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38537934 | Different Oncogenes and Reproductive Histories Shape the Progression of Distinct Premalignant Clones in Multistage Mouse Breast Cancer Models. | Am J Pathol | 2024 | https://conductscience.org/library/papers/38537934 | PubMed |
| 33842308 | Advances in Rodent Models for Breast Cancer Formation, Progression, and Therapeutic Testing. | Front Oncol | 2021 | https://conductscience.org/library/papers/33842308 | PubMed |
| 32376245 | IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis. | Dev Biol | 2020 | https://conductscience.org/library/papers/32376245 | PubMed |
| 29651417 | Aging Mouse Models Reveal Complex Tumor-Microenvironment Interactions in Cancer Progression. | Front Cell Dev Biol | 2018 | https://conductscience.org/library/papers/29651417 | PubMed |
| 28865492 | Pathobiology of the 129:Stat1 -/- mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotype. | Breast Cancer Res | 2017 | https://conductscience.org/library/papers/28865492 | PubMed |
| 27019623 | Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. | Int J Biol Sci | 2016 | https://conductscience.org/library/papers/27019623 | PubMed |
| 26058079 | Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy. | Cancer Cell | 2015 | https://conductscience.org/library/papers/26058079 | PubMed |
| 22067349 | Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells. | Breast Cancer Res | 2011 | https://conductscience.org/library/papers/22067349 | PubMed |
| 22056952 | MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors. | Mod Pathol | 2012 | https://conductscience.org/library/papers/22056952 | PubMed |
| 20630995 | Of mice and women: A short history of mouse mammary cancer research with an emphasis on the paradigms inspired by the transplantation method. | Cold Spring Harb Perspect Biol | 2010 | https://conductscience.org/library/papers/20630995 | PubMed |
| 20574808 | Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies. | J Mol Med (Berl) | 2010 | https://conductscience.org/library/papers/20574808 | PubMed |
| 20521088 | The pathology of EMT in mouse mammary tumorigenesis. | J Mammary Gland Biol Neoplasia | 2010 | https://conductscience.org/library/papers/20521088 | PubMed |
| 19344510 | Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype. | Breast Cancer Res | 2009 | https://conductscience.org/library/papers/19344510 | PubMed |
| 18686517 | Genomic pathology for genomic biology. | Pathologica | 2008 | https://conductscience.org/library/papers/18686517 | PubMed |
| 18654840 | Mus tales: a hands-on view. | J Mammary Gland Biol Neoplasia | 2008 | https://conductscience.org/library/papers/18654840 | PubMed |
| 18495924 | Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18495924 | PubMed |
| 18040269 | 'One medicine---one pathology': are veterinary and human pathology prepared? | Lab Invest | 2008 | https://conductscience.org/library/papers/18040269 | PubMed |
| 17109643 | Establishment and characterization of new mammary adenocarcinoma cell lines derived from double transgenic mice expressing GFP and neu oncogene. | Cell Prolif | 2006 | https://conductscience.org/library/papers/17109643 | PubMed |
| 17030631 | Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. | Mol Cell Biol | 2006 | https://conductscience.org/library/papers/17030631 | PubMed |
| 16497871 | c-myc amplifications in primary breast carcinomas and their local recurrences. | J Clin Pathol | 2006 | https://conductscience.org/library/papers/16497871 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1887859
GET https://conductscience.org/api/papers/v1/1887859/cited_by?page=2